Tickerplace logo

Tickerplace

Minerva Neurosciences, Inc. logo

NERVMinerva Neurosciences, Inc.

NERV Stock Price, Valuation & Chart | Minerva Neurosciences, Inc.

Compare
$4.480+0.00 (+0.00%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyNERV intrinsic valueNERV calculated fair value vs price
OverviewFinancialsDividendsRatios

NERV Historical price chart

NERV Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization208.72M
PE Ratio-1.04
EPS-4.29
Trading Volume82.83K
Today's High/Low4.6/4.45
Dividend Yield0.00
52 Week High/Low12.46/1.93
Shares Outstanding46.59M
NERV Financial Statement
NERV Analyst ratings
NERV Analysis & performance metrics

NERV Company profile

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central…

NERV Management team

Management
Frederick W. Ahlholm CPACFO
Senior Vice President, Chief Financial Officer & Secretary
William B. Boni
Vice President of Investor Relations & Corporate Communications
Geoffrey Robin Race F.C.M.A., M.B.A.
President
Joseph ReillyCOO
Senior Vice President & Chief Operating Officer
Michael Davidson M.D.
Chief Medical Officer
Remy Luthringer Ph.D.CEO
Executive Chairman & Chief Executive Officer
Total 6 executives

NERV Frequently asked questions

What is Minerva Neurosciences, Inc. (NERV) Stock Price?

Current stock price of Minerva Neurosciences, Inc. (NERV) stock is $4.480. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Minerva Neurosciences, Inc. (NERV) stock is 82.83K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Minerva Neurosciences, Inc. (NERV) stock price going up or down today?

The stock price of Minerva Neurosciences, Inc. (NERV) can change with earnings, company news, and overall market sentiment. Minerva Neurosciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Minerva Neurosciences, Inc. stock expensive at its current price?

Whether Minerva Neurosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NERV on this page is -1.04. EPS on this page is -4.29. Compare those figures with peers and growth expectations before deciding if the current Minerva Neurosciences, Inc. price is justified.

How has the stock price of Minerva Neurosciences, Inc. (NERV) performed historically?

Historical performance for Minerva Neurosciences, Inc. (NERV) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NERV reacted to past earnings and market events.

Should I buy Minerva Neurosciences, Inc. (NERV) stock, at this price?

Buying Minerva Neurosciences, Inc. (NERV) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.